A subsequent report that also analyzed the CGGA dataset and TCGA dataset along with the GSE16011 dataset, respectively, supported these earlier results, showing that HAVCR2 gene expression was highest in the mesenchymal subgroup of glioblastoma patients and that these patients displayed shorter survival [72]. Here, HAVCR2 is linked to glioblastoma.